WANTAI BioPharm

Wantai BioPharm is a pioneering high-tech enterprise dedicated to the research and development of biological diagnostic reagents and vaccines. With nine subsidiaries spanning diverse sectors including diagnostic reagents, quality control products, vaccines, and medical devices, it has established a strong presence in the industry. Since its inception in 1991, Wantai BioPharm has evolved into a leading HIV diagnostic reagent production hub in the Asia-Pacific region and a renowned immunodiagnostic reagent base, serving as a national high-tech industrialization demonstration project in China. Continuous innovation and development are at the core of Wantai BioPharm, with six global firsts and six national firsts to its credit. Its comprehensive product portfolio encompasses a wide range of diagnostic reagents such as ELISA, Dot ELISA, GICT, chemiluminescence, nucleic acid, and biochemical tests, in addition to vaccines and quality control products. Today, Wantai BioPharm's products are exported to over 80 countries worldwide. Committed to leveraging cutting-edge biotechnology, Wantai BioPharm transforms these advancements into high-quality products, offering comprehensive services to the public while safeguarding global health.